Diane K. Jorkasky, M.D. FACP brings over three decades of experience in all stages of clinical development to the APIE Therapeutics board.
Read MoreNews
RTI International Licenses Portfolio of Compounds
The agreement advances APIE Therapeutics’ pursuit of a treatment for idiopathic pulmonary fibrosis, a rare lung disease
Read MoreEvents
Venture Connect 2021
March 23, 2021
Venture Connect Online is a digital experience that is designed to maximize the visibility of growing companies and help entrepreneurs…
